Home Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems
Article Open Access

Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems

  • Rafał Muc EMAIL logo , Agnieszka Saracen and Iwona Grabska-Liberek
Published/Copyright: April 18, 2018
Download Article (PDF)
Open Medicine
From the journal Open Medicine Volume 13 Issue 1

Abstract

Diabetes Mellitus (DM) is one of the biggest healthcare and financial problems worldwide. The disease is strongly associated with microvascular and macrovascular complications, causing co-existing diseases like Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy. Annual healthcare expenditures for diabetes treatment and complications prevention cost 727 billion USD in year 2017.

Diabetes Mellitus, Diabetic Retinopathy and Diabetic Retinal Neuropathy are closely related diseases - originating from incorrectly controlled glycemia, blood pressure and lipid levels in the course of increasing resistance of the body tissues to insulin.

Irrespectively of thorough programs for Diabetes Mellitus prevention and treatment, Diabetic Retinopathy management requires targeted treatment strategies for both microvasculopathy and retinal neurodegeneration, to delay disease severity course and risk of blindness.

The study and conclusions in this article are based on web-available data and officially published articles related to the diabetes mellitus and associated diseases – Diabetic Retinopathy and Diabetic Retinal Neuropathy. The articles have been reviewed and analyzed to assess mutual relations between the discussed diseases.

Keywords: Diabetes; Mellitus; Diabetic Retinopathy; DR; Diabetic Retinal Neuropathy; DRN

1 Introduction

Undeniably, Diabetes Mellitus (DM) is one of the biggest healthcare and financial problems worldwide that drains private and healthcare budgets every year. According to the International Diabetes Federation, in year 2017 there were 424.9 million adults with Diabetes Mellitus globally. Despite countless medical studies, publications and treatment guidelines related to DM, hundreds of thousands physicians engaged, 50 percent (212.4 million) of DM patients are unaware of their disease. Annual worldwide healthcare costs for diabetes treatment and complications prevention are calculated at 727 billion USD in year 2017 and 776 billion USD for year 2045 respectively. In the following years significant growth of expenditures on DM treatment is expected, mainly due to growing incidence and prevalence of mellitus. The disease incidence is a natural consequence of unhealthy nutrition, lack of physical activity leading to obesity and resistance of the body tissues to insulin over a long period of time. Continuously increasing life expectancy additionally impacts prevalence and duration of DM, so undoubtedly the overall number of DM patients treated every year will increase worldwide [2].

Diabetes Mellitus is strongly associated with microvascular and macrovascular complications [3]. Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy are present in up to 50 percent of patients with diabetes mellitus [3, 4].

The rationale for the study is to review recent publications related to Diabetic Mellitus, Diabetic Retinopathy and Diabetic Retinal Neuropathy and confirm direct associations and mutual dependency between the DR and DRN. Concluding research studies, Diabetic Retinopathy is not just the disease of microvascular degeneration, but also neurons atrophy in the retina. Consequently, a twofold strategy for DR treatment, neural and vascular protection from structural and functional damage or degeneration is required.

2 Materials and methods

The study and conclusions in this article are based on web-available data, officially published articles, related to diabetes mellitus and associated diseases – Diabetic Retinopathy and Diabetic Retinal Neuropathy. The articles have been reviewed and analyzed to assess mutual relations between the discussed diseases.

3 Results

Diabetic Retinopathy (DR) is an eye disease, a long-term developing microvascular complication as a natural course of Diabetes Mellitus. The incidence of DR equals to 33.2 percent of Diabetes Mellitus cases - 4 years after the onset of the DM, 45.1 percent after five years and 67.1 percent after 10 years respectively. Diabetic Retinopathy significantly increases risk of visual impairment. After 4 years of DM course 8.7 percent of patients develop Proliferative Diabetic Retinopathy (PDR) and 24 percent Diabetic Macular Edema (DME). 10 percent of DM patients are diagnosed as having severe visual loss (SVL) [5, 6]. There are several risk factors, which play an important role in DR development - improperly controlled glycemia, blood pressure and lipid levels during the diabetes mellitus course. The longer DM lasts, the higher probability of DR development is confirmed [7].

Treatment costs of DR play an important role in the overall expenses of diabetes management. According to Heintz, Wirehn et al., the annual average healthcare cost for PDR is calculated at 257 EUR and for DME 216 EUR per person per year. The annual costs for DR treatment equals to 106 thousand EUR per 100 thousand inhabitants [8].

Assuming the exchange rate EUR to USD 1.2:1, PDR treatment costs might represent up to 10 percent and DME 8 percent of the overall diabetes management costs.

Diabetic Neuropathy (DN) is a nerve damaging disease that develops over time due to Diabetes Mellitus. DN furthers mortality and morbidity of DM patients. The disease is the cause of 50-75 percent non-traumatic amputations and up to 25 percent neuropathic pain in mellitus patients [9]. A quarter of mellitus patients attending diabetic clinics report Diabetic Neuropathy symptoms by themselves and over half of them have been diagnosed with DN after basic clinical tests [9, 10, 11].

According to the US National Institute of Diabetes and Digestive and Kidney Diseases, 50 to 70 percent of DM patients have some form of neuropathy [12].

There are four basic types of Diabetic Neuropathy [12]:

  1. Peripheral neuropathy that affects the upper and lower limbs, causing pain and or loss of feeling.

  2. Autonomic neuropathy impacting heart and blood vessels, digestive systems, urinary tracts, sex organs and eyes.

  3. Proximal neuropathy causing pain in thighs, hips, buttocks or legs predominantly on the side of the body.

  4. Focal neuropathy affecting selective areas of the body including eyes, facial and ear muscles, chest, abdomen and lower limbs [12].

Just Diabetic Peripheral Neuropathy might represent up to 27 percent of overall diabetes management cost, and in the United States alone, these costs are estimated at between 10.9 to 13.7 billion USD [13].

Dworkin et al. calculated the cost for painful diabetic peripheral neuropathy at 6.2 thousand USD per patient, which is even higher than the average costs for DM treatment [14].

Diabetic Retinopathy is commonly recognized as microvascular degeneration as a result of chronic hyperglycemia. But retina is not just a network of blood vessels that undergo structural and functional changes during the primary disease course. It is vascularized neural tissue,; therefore Diabetic Retinopathy management requires targeted strategies for both microvasculopathy and neurodegeneration of the retina [15].

The loss of neurons in histopathologic studies among DR patients was reported more than forty years ago [15]. Recent studies with short-wave automated perimetry and frequency doubling perimetry tests confirm neural degeneration in DM patients with no or limited vascular retinopathy [15]. It is suggested that DM patients’ eyes neurodegeneration has sources in the inflammatory process, where antibodies, inflammatory cells and amino acids damage vessels and neurons. Consequently, imbalanced inflammation leads to over-expression of growth factors like VEGF, causing visual impairment [15].

Imbalance between retinal cell survival neutrophins and inflammatory mediators among DM patients is presented in the Figure 3.

Figure 1 Correlation of the Diabetic Retinopathy with duration of Diabetes Mellitus [7].
Figure 1

Correlation of the Diabetic Retinopathy with duration of Diabetes Mellitus [7].

Figure 2 Effect of disease duration and age on prevalence of Diabetic Neuropathy [11].For both T1DM and T2DM, duration of diabetes (left) as well as age of patient (right) is correlated to the incidence of diabetic neuropathy [11].
Figure 2

Effect of disease duration and age on prevalence of Diabetic Neuropathy [11].

For both T1DM and T2DM, duration of diabetes (left) as well as age of patient (right) is correlated to the incidence of diabetic neuropathy [11].

Figure 3 Concept of imbalance between pro-survival factors and inflammatory mediators [15]. Diabetes disturbs the homeostatic equilibrium of the retina. Under normal conditions, there is an equilibrium in which pro-survival and anti-inflammatory stimuli maintain retinal cell survival and function. In diabetes, pro-survival (neurotrophic) inputs may be reduced and pro-inflammatory cytokines, chemokines, and cellular responses increased. Together, these processes accelerate retinal cell death and increase vascular permeability and occlusion, thus impairing vision [15].
Figure 3

Concept of imbalance between pro-survival factors and inflammatory mediators [15]. Diabetes disturbs the homeostatic equilibrium of the retina. Under normal conditions, there is an equilibrium in which pro-survival and anti-inflammatory stimuli maintain retinal cell survival and function. In diabetes, pro-survival (neurotrophic) inputs may be reduced and pro-inflammatory cytokines, chemokines, and cellular responses increased. Together, these processes accelerate retinal cell death and increase vascular permeability and occlusion, thus impairing vision [15].

Sohn et al. recognize Retinal Diabetic Neuropathy (RDN) as independent from retina vessels ischemia. In the groundbreaking longitudinal study with human eye and mice tissue, researches proved that retinal neurodegeneration precedes microvascular changes in the Diabetes Mellitus eye. The neurodegeneration is independent from glycated hemoglobin, age and gender [16].

In the study among 45 patients with Diabetes Mellitus and with lack of minimal Diabetic Retinopathy diagnosed, using optical coherence tomography, researchers observed progressive thickness loss of the nerve fiber layer (NFL), the ganglion cell (GC) and inner plexiform layer (IPL). NFL thickness among DM patients without retinopathy is presented in Figure 4 [16].

Figure 4 Nerve fiber layer thickness in DM patients with no retinopathy [16].(A and B) Sections of eye from human donors with DM and no retinopathy (A) and from age-matched controls (B) stained with γ-synuclein antibody to immunolabel GCs and the NFL (green); DAPI nuclear counterstaining is blue; the red-orange signal at the level of the RPE is caused by auto fluorescence. (C) The NFL was significantly thinner in the diabetic eye (n = 6) than in controls (n = 5). (D) Retinal capillary density was measured from whole-mount sections; vessels were immunolabeled with biotinylated UEA-I followed by avidin conjugated to Texas Red (Fig. S4). No significant difference in retinal capillary density was found in the eye from diabetic donors (n = 6) and from controls (n= 5) [16].
Figure 4

Nerve fiber layer thickness in DM patients with no retinopathy [16].

(A and B) Sections of eye from human donors with DM and no retinopathy (A) and from age-matched controls (B) stained with γ-synuclein antibody to immunolabel GCs and the NFL (green); DAPI nuclear counterstaining is blue; the red-orange signal at the level of the RPE is caused by auto fluorescence. (C) The NFL was significantly thinner in the diabetic eye (n = 6) than in controls (n = 5). (D) Retinal capillary density was measured from whole-mount sections; vessels were immunolabeled with biotinylated UEA-I followed by avidin conjugated to Texas Red (Fig. S4). No significant difference in retinal capillary density was found in the eye from diabetic donors (n = 6) and from controls (n= 5) [16].

The most recent studies suggest neurodegeneration in DM patients’ eyes as not only accompanying Diabetic Retinopathy, but also having a direct correlation. Lynch and Abramoff argue that DRN is a cause of DR, but further studies are required to prove this hypothesis [17].

Araszkiewicz and Ziolkiewicz directly associate retinal neurodegeneration with a course Diabetes Mellitus, where neurons apoptosis is first observed in retinal ganglion cells (RGC) [18]. The neurodegeneration in diabetic patients co-occurs with symptomatic changes in glial cells. It results in over-expression of glial acidic fibrillar protein, weakens astrocyte functions and activation of microglial cells. Also it initiates pro-inflammatory cytokines release and finally neuronal cell death [18].

The retina endothelial cells of micro-vessels determine a blood retinal barrier, which protects neural tissue from damage. An imbalance in metabolic processes in the retina can cause both neurodegeneration and vasculopathy resulting in structural changes in the retina, visual acuity impairment and finally, structural diabetic retinopathy [17, 18].

Parallel to DR consequences of neurovascular disorders in the retina might result in open-angle glaucoma (OAG). DM patients increase the incidence of primary glaucoma by 36 percent [19, 20]. From 32 percent to 43 percent of DM patients with secondary glaucoma is caused by Proliferative Diabetic Retinopathy [21].

Key mechanisms and associations leading to the Diabetic Retinopathy are presented in Figure 5 [18,19,20,21,22].

Figure 5 Key mechanisms leading to the DR [18].Schematic representation of the main mechanisms leading to Diabetic Retinopathy, where neural and vascular damage leads to Diabetic Retinopathy. In addition to DR development neuro-vascular damage might cause open-angle glaucoma [18].
Figure 5

Key mechanisms leading to the DR [18].

Schematic representation of the main mechanisms leading to Diabetic Retinopathy, where neural and vascular damage leads to Diabetic Retinopathy. In addition to DR development neuro-vascular damage might cause open-angle glaucoma [18].

4 Discussion

Diabetic Retinopathy management requires targeted treatment strategies for both microvasculopathy and retinal neurodegeneration to delay disease severity course and risk of blindness [22]. Retina neuroprotection should be considered a crucial part of the overall diabetic retinopathy treatment. There are several experimental studies, suggesting Angiotensin II Type 1 blockers, Lutein, Green Tea and Ascorbic Acid as potent neuroprotective agents [23].

Other potential neurotrophic components, such as pigment epithelium-derived factor (PEDF), nerve growth factors (NGF), brain-derived neurotrophic factor (BDNF) might also enhance the number of treatment options for neuroprotection in diabetic retinopathy patients.

Some experimental studies suggest neuroprotection role in the diabetic’s eye retina by Memantine - glutamate receptor antagonist, Pentazocine - a specific sigma receptor-1 ligand and Gabapentin - a specific inhibitor of the neuronal, cytosolic isoform of branched chain amino-transferase (BCATc) [23]. Randomized and clinically controlled studies are required to prove retinal neuroprotection efficacy and safety of the mentioned above therapeutic options [23].

In the multi-center, two years prospective, randomized and controlled clinical study Eurocondor (project ID 278040) with target population of a representative group of male and female type two diabetic patients (n= 450) the somatostatin selective agonists (SST) and brominide have been assessed to check their aptitude of neurodegeneration prevention in early stages of Diabetic Retinopathy. Somatostatin and bromonide have shown a positive effect inhibiting the progression in those patients in whom some degree of neurodegeneration is already present. However this therapeutic option does not seem to be useful for the prevention of development of neurodegeneration in patients with best retinal function. A secondary result of the study, somatostatin proved an efficacy in arresting vasculopathy progression compared to a placebo [24].

Irrespectively of new prospective therapies that would allow to step up with prevention or subjugation neuro and vascular damage in diabetic eye and better Diabetic Retinopathy control, standardization of neural abnormalities detection methods are needed. Current multifocal electroretinography (mf-ERG) and frequency domain optical coherence tomography (fd-OCT) are used to observe morphological and functional changes of nerves in the retina, even before microvascular abnormality. Evaluation of changes in the nerve fiber layer, ganglion cell density, photoreceptor changes, thickness of the retina will be crucial in further perspective of the two fold strategy for DR treatment - neural and vascular protection from structural and functional damage or degeneration [24].

Tel: 0048 668 138 492

  1. Conflicts of interest: The authors have no conflicts of interest to declare.

References

[1] Cho N.H., Kirigia J., Mbanya J.C., Ogurstova K., Guariguata L., Rathmann W., et al., IDF Diabetes Atlas, Eighth Edition, 2017, https://www.idf.org/e-library/epidemiology-research/diabetes-atlas.htmlSearch in Google Scholar

[2] Kontis V., Bennet E.J., Mathers D.C., Li G., Foreman K., Ezzatiet M., Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble, Lancet, 2017, 389: 1323–1335,http://dx.doi.org/10.1016/S0140-6736(16)32381-3238910.1016/S0140-6736(16)32381-9Search in Google Scholar

[3] Cade WT. Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting. Physical Therapy, 2008, 88(11):1322-1335, 10.2522/ptj.20080008Search in Google Scholar

[4] UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance, Diabetologia, 1991, 34:877–890, https://www.ncbi.nlm.nih.gov/pubmed/177835310.1007/BF00400195Search in Google Scholar

[5] Zheng Y., He M., Congdon N., The worldwide epidemic of diabetic retinopathy. Indian Journal of Ophthalmology, 2012, 60(5):428-431, 10.4103/0301-4738.100542Search in Google Scholar

[6] Wong T.Y., Mwamburi M., Klein R., Larsen M., Flynnc H., Hernandez-Medina M., et al., Rates of Progression in Diabetic Retinopathy During Different Time Periods: A systematic review and meta-analysis, Diabetes Care, 2009, 32(12):2307-2313, 10.2337/dc09-0615Search in Google Scholar

[7] Reprinted from: El-Bab M.F., Shawky N., Al-Sisi A., Akhtar M., Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia, Clinical Ophthalmology (Auckland, NZ), 2012, 6:269-276, Material from this publication has been used under CC-BY-NC Dove Medical Press Limited license. 10.2147/OPTH.S27363Search in Google Scholar

[8] Heintz E., Wirèhn A.B., Peebo B.B., Rosenqvist U., Levin L.A., Diabetologia, 2010, 53: 2147, https://doi.org/10.1007/s00125-010-1836-310.1007/s00125-010-1836-3Search in Google Scholar

[9] Vinik A., Casellini C., Nevoret M.L., Diabetic Neuropathies, 2015, https://www.ncbi.nlm.nih.gov/books/NBK279175Search in Google Scholar

[10] Vinik A: Diabetic Neuropathy: Pathogenesis and Therapy, Am. J. Med., 1999, 107 (2B):17S-26S10.1016/S0002-9343(99)00009-1Search in Google Scholar

[11] Reprinted from Edwards J.L., Vincent A., Cheng T., Feldman E.L., Diabetic Neuropathy: Mechanisms to Management, Pharmacology & therapeutics, 2008, 120(1):1-34, with permission from Elsevier 10.1016/j.pharmthera.2008.05.005Search in Google Scholar PubMed PubMed Central

[12] Nerve Damage (Diabetic Neuropathies), National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication, 2009, 09–3185, https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/nerve-damage-diabetic-neuropathiesSearch in Google Scholar

[13] Gordois A., Scuffham P., Shearer A., Oglesby A., Janet Ash Tobian A.J., The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S., Diabetes Care, 2003, 26 (6) 1790-1795, https://doi.org/10.2337/diacare.26.6.179010.2337/diacare.26.6.1790Search in Google Scholar PubMed

[14] Dworkin R., Panarites C., Chen J., Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on healthcare costs, The Journal of Pain, 2009, Volume 10, Issue 4, S17 http://dx.doi.org/10.1016/j.jpain.2009.01.07510.1016/j.jpain.2009.01.075Search in Google Scholar

[15] Reprinted from Antonetti D.A., Barber J.A., Bronson K.S., Freeman M.W., Gardner W.T., Jefferson S.L., Diabetic Retinopathy - Seeing Beyond Glucose-Induced Microvascular Disease; American Diabetes Association, Diabetes, 2006, 55 (9) 2401-2411. Copyright and all rights reserved. Material from this publication has been used with the permission of American Diabetes Association. https://doi.org/10.2337/db05-163510.2337/db05-1635Search in Google Scholar

[16] Reprinted from: Sohn E.H., van Dijk H.W., Jiao C., Kok H.B.P., Jeong W., Demirkaya N., et al., Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus, PNAS, 2016, 113(19):E2655-E2664, Material from this publication has been used with the permission of Proceedings of the National Academy of Sciences of the United States of America, 10.1073/pnas.1522014113Search in Google Scholar

[17] Lynch K.S.,, Abràmoff D.M., Diabetic retinopathy is a neurodegenerative disorder, Vision Research, 2017, Volume 139, 101-107, https://doi.org/10.1016/j.visres.2017.03.00310.1016/j.visres.2017.03.003Search in Google Scholar

[18] Araszkiewicz A., Zozulinska-Ziolkiewicz D., Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective, Current Neuropharmacology. 2016, 14(8):805-809, 10.2174/1570159X14666160225154536Search in Google Scholar

[19] Mitchell P., Smith W., Chey T., Healey P.R., Open-angle glaucoma and diabetes: the Blue Mountains eye study, Ophthalmology, 1997, 104(4):712–718, http://dx.doi.org/10.1016/S0161-6420(97)30247-410.1016/S0161-6420(97)30247-4Search in Google Scholar

[20] Zhao Y-X., Chen X-W., Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies, International Journal of Ophthalmology, 2017, 10(9):1430-1435 10.18240/ijo.2017.09.16,Search in Google Scholar PubMed PubMed Central

[21] Jeganathan V.S.E., Wang J.J., Wong T.Y., Ocular Associations of Diabetes Other Than Diabetic Retinopathy, Diabetes Care, 2008, 31(9):1905-1912, 10.2337/dc08-0342Search in Google Scholar PubMed PubMed Central

[22] Simό R., Hernández C., Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives, Trends Endocrinol. Metab., 2014, 25(1):2333, http://dx.doi.org/10.1016/j.tem.2013.09.00510.1016/j.tem.2013.09.005Search in Google Scholar PubMed

[23] Ola M.S., Nawaz M.I., Khan H.A., Alhomida A.S., Neurodegeneration and Neuroprotection in Diabetic Retinopathy, International Journal of Molecular Sciences, 2013, 14(2):2559-2572, 10.3390/ijms14022559Search in Google Scholar PubMed PubMed Central

[24] European Consortium for the Early Treatment of Diabetic Retinopathy, Project ID: 278040 http://cordis.europa.eu/result/rcn/189871_pl.htmlSearch in Google Scholar

Received: 2017-10-28
Accepted: 2018-02-27
Published Online: 2018-04-18

© 2018 Rafał Muc et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Regular Articles
  2. Cleidocranial dysplasia-dental disorder treatment and audiology diagnosis
  3. A hybrid neural network – world cup optimization algorithm for melanoma detection
  4. Early administration of venovenous extracorporeal life support for status asthmaticus during anaesthetic induction: case report and literature review
  5. Assessment of maximal isometric hand grip strength in school-aged children
  6. Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting
  7. Value of continuous video EEG and EEG responses to thermesthesia stimulation in prognosis evaluation of comatose patients after cardiopulmonary resuscitation
  8. Platelet-rich plasma protects HUVECs against oX-LDL-induced injury
  9. Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China
  10. Small-cell lung cancer presenting as fatal pulmonary hemorrhage
  11. Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
  12. Prognosis of treatment outcomes by cognitive and physical scales
  13. The efficacy of radiofrequency hyperthermia combined with chemotherapy in the treatment of advanced ovarian cancer
  14. Arcuate Fasciculus in Autism Spectrum Disorder Toddlers with Language Regression
  15. Aesthetic dental procedures: legal and medico-legal implications
  16. Blood transfusion in children: the refusal of Jehovah’s Witness parents’
  17. Burnout among anesthetists and intensive care physicians
  18. Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis
  19. Ethical and legal issues in gestational surrogacy
  20. Effects of arginine vasopressin on migration and respiratory burst activity in human leukocytes
  21. Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems
  22. Pituitary dysfunction from an unruptured ophthalmic internal carotid artery aneurysm with improved 2-year follow-up results: A case report
  23. Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
  24. Piercing and tattoos in adolescents: legal and medico-legal implications
  25. The central importance of information in cosmetic surgery and treatments
  26. Penile calciphylaxis in a patient with end-stage renal disease: a case report and review of the literature
  27. Serum CA72-4 as a biomarker in the diagnosis of colorectal cancer: A meta-analysis
  28. Association between uric acid and metabolic syndrome in elderly women
  29. Distinct expression and prognostic value of MS4A in gastric cancer
  30. MAPK pathway involved in epidermal terminal differentiation of normal human epidermal keratinocytes
  31. Association of central obesity with sex hormonebinding globulin: a cross-sectional study of 1166 Chinese men
  32. Successful endovascular therapy in an elderly patient with severe hemorrhage caused by traumatic injury
  33. Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
  34. Related factors of early mortality in young adults with cerebral hemorrhage
  35. Growth suppression of glioma cells using HDAC6 inhibitor, tubacin
  36. Post-stroke upper limb spasticity incidence for different cerebral infarction site
  37. The esophageal manometry with gas-perfused catheters
  38. MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
  39. Genetic testing: ethical aspects
  40. Intervention for physician burnout: A systematic review
  41. The melanin-concentrating hormone system in human, rodent and avian brain
  42. Clinical effects of piribedil in adjuvant treatment of Parkinson’s Disease: A meta-analysis
  43. Identification of a novel BRAF Thr599dup mutation in lung adenocarcinoma
  44. Adrenal incidentaloma – diagnostic and treating problem – own experience
  45. Common illnesses in tropical Asia and significance of medical volunteering
  46. Genetic risk in insurance field
  47. Genetic testing and professional responsibility: the italian experience
  48. The mechanism of mitral regurgitant jets identified by 3-dimensional transesophageal echocardiography
  49. Control of blood pressure and cardiovascular outcomes in type 2 diabetes
  50. Pseudomesotheliomatous primary squamous cell lung carcinoma: The first case reported in Turkey and a review of the literature
  51. Diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies
  52. GPER was associated with hypertension in post-menopausal women
  53. Metabolic activity of sulfate-reducing bacteria from rodents with colitis
  54. Association of miRNA122 & ADAM17 with lipids among hypertensives in Nigeria
  55. The efficacy and safety of enoxaparin: a meta-analysis
  56. Cuffed versus uncuffed endotracheal tubes in pediatrics: a meta-analysis
  57. Thresholding for medical image segmentation for cancer using fuzzy entropy with level set algorithm
  58. Sleep deprivation in Intensive Care Unit – systematic review
  59. Benefits of computed tomography in reducing mortality in emergency medicine
  60. Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
  61. Limits of professional competency in nurses working in Nicu
  62. MDA-19 suppresses progression of melanoma via inhibiting the PI3K/Akt pathway
  63. The effect of smoking on posttraumatic pseudoarthrosis healing after internal stabilization, treated with platelet rich plasma (PRP)
  64. Partial deletion of the long arm of chromosome 7: a case report
  65. Meta-analysis of PET/CT detect lymph nodes metastases of cervical cancer
  66. High Expression of NLRC5 is associated with prognosis of gastric cancer
  67. Is monitoring mean platelet volume necessary in breast cancer patients?
  68. Resectable single hepatic epithelioid hemangioendothelioma in the left lobe of the liver: a case report
  69. Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
  70. The CCR5-Delta32 genetic polymorphism and HIV-1 infection susceptibility: a meta-analysis
  71. Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro
  72. Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions
  73. Analysis of patient satisfaction with emergency medical services
  74. Guillain-Barré syndrome and Low back pain: two cases and literature review
  75. HELLP syndrome complicated by pulmonary edema: a case report
  76. Pharmacokinetics of vancomycin in patients with different renal function levels
  77. Recurrent chronic subdural hematoma: Report of 13 cases
  78. Is awareness enough to bring patients to colorectal screening?
  79. Serum tumor marker carbohydrate antigen 125 levels and carotid atherosclerosis in patients with coronary artery disease
  80. Plastic treatment for giant pseudocyst after incisional hernia mesh repair: a case report and comprehensive literature review
  81. High expression levels of fascin-1 protein in human gliomas and its clinical relevance
  82. Thromboembolic complications following tissue plasminogen activator therapy in patients of acute ischemic stroke - Case report and possibility for detection of cardiac thrombi
  83. The effects of gastrointestinal function on the incidence of ventilator-associated pneumonia in critically ill patients
  84. A report of chronic intestinal pseudo-obstruction related to systemic lupus erythematosus
  85. Risk model in women with ovarian cancer without mutations
  86. Direct oral anticoagulants and travel-related venous thromboembolism
  87. How bispectral index compares to spectral entropy of the EEG and A-line ARX index in the same patient
  88. Henoch-schonlein purpura nephritis with renal interstitial lesions
  89. Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
  90. CD5 and CD43 expression are associate with poor prognosis in DLBCL patients
  91. Combination of novoseven and feiba in hemophiliac patients with inhibitors
https://doi.org/10.1515/med-2018-0008
Keywords for this article
Diabetes; Mellitus; Diabetic Retinopathy; DR; Diabetic Retinal Neuropathy; DRN
Creative Commons
BY-NC-ND 4.0

Articles in the same Issue

  1. Regular Articles
  2. Cleidocranial dysplasia-dental disorder treatment and audiology diagnosis
  3. A hybrid neural network – world cup optimization algorithm for melanoma detection
  4. Early administration of venovenous extracorporeal life support for status asthmaticus during anaesthetic induction: case report and literature review
  5. Assessment of maximal isometric hand grip strength in school-aged children
  6. Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting
  7. Value of continuous video EEG and EEG responses to thermesthesia stimulation in prognosis evaluation of comatose patients after cardiopulmonary resuscitation
  8. Platelet-rich plasma protects HUVECs against oX-LDL-induced injury
  9. Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China
  10. Small-cell lung cancer presenting as fatal pulmonary hemorrhage
  11. Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
  12. Prognosis of treatment outcomes by cognitive and physical scales
  13. The efficacy of radiofrequency hyperthermia combined with chemotherapy in the treatment of advanced ovarian cancer
  14. Arcuate Fasciculus in Autism Spectrum Disorder Toddlers with Language Regression
  15. Aesthetic dental procedures: legal and medico-legal implications
  16. Blood transfusion in children: the refusal of Jehovah’s Witness parents’
  17. Burnout among anesthetists and intensive care physicians
  18. Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis
  19. Ethical and legal issues in gestational surrogacy
  20. Effects of arginine vasopressin on migration and respiratory burst activity in human leukocytes
  21. Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems
  22. Pituitary dysfunction from an unruptured ophthalmic internal carotid artery aneurysm with improved 2-year follow-up results: A case report
  23. Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
  24. Piercing and tattoos in adolescents: legal and medico-legal implications
  25. The central importance of information in cosmetic surgery and treatments
  26. Penile calciphylaxis in a patient with end-stage renal disease: a case report and review of the literature
  27. Serum CA72-4 as a biomarker in the diagnosis of colorectal cancer: A meta-analysis
  28. Association between uric acid and metabolic syndrome in elderly women
  29. Distinct expression and prognostic value of MS4A in gastric cancer
  30. MAPK pathway involved in epidermal terminal differentiation of normal human epidermal keratinocytes
  31. Association of central obesity with sex hormonebinding globulin: a cross-sectional study of 1166 Chinese men
  32. Successful endovascular therapy in an elderly patient with severe hemorrhage caused by traumatic injury
  33. Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
  34. Related factors of early mortality in young adults with cerebral hemorrhage
  35. Growth suppression of glioma cells using HDAC6 inhibitor, tubacin
  36. Post-stroke upper limb spasticity incidence for different cerebral infarction site
  37. The esophageal manometry with gas-perfused catheters
  38. MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
  39. Genetic testing: ethical aspects
  40. Intervention for physician burnout: A systematic review
  41. The melanin-concentrating hormone system in human, rodent and avian brain
  42. Clinical effects of piribedil in adjuvant treatment of Parkinson’s Disease: A meta-analysis
  43. Identification of a novel BRAF Thr599dup mutation in lung adenocarcinoma
  44. Adrenal incidentaloma – diagnostic and treating problem – own experience
  45. Common illnesses in tropical Asia and significance of medical volunteering
  46. Genetic risk in insurance field
  47. Genetic testing and professional responsibility: the italian experience
  48. The mechanism of mitral regurgitant jets identified by 3-dimensional transesophageal echocardiography
  49. Control of blood pressure and cardiovascular outcomes in type 2 diabetes
  50. Pseudomesotheliomatous primary squamous cell lung carcinoma: The first case reported in Turkey and a review of the literature
  51. Diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies
  52. GPER was associated with hypertension in post-menopausal women
  53. Metabolic activity of sulfate-reducing bacteria from rodents with colitis
  54. Association of miRNA122 & ADAM17 with lipids among hypertensives in Nigeria
  55. The efficacy and safety of enoxaparin: a meta-analysis
  56. Cuffed versus uncuffed endotracheal tubes in pediatrics: a meta-analysis
  57. Thresholding for medical image segmentation for cancer using fuzzy entropy with level set algorithm
  58. Sleep deprivation in Intensive Care Unit – systematic review
  59. Benefits of computed tomography in reducing mortality in emergency medicine
  60. Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
  61. Limits of professional competency in nurses working in Nicu
  62. MDA-19 suppresses progression of melanoma via inhibiting the PI3K/Akt pathway
  63. The effect of smoking on posttraumatic pseudoarthrosis healing after internal stabilization, treated with platelet rich plasma (PRP)
  64. Partial deletion of the long arm of chromosome 7: a case report
  65. Meta-analysis of PET/CT detect lymph nodes metastases of cervical cancer
  66. High Expression of NLRC5 is associated with prognosis of gastric cancer
  67. Is monitoring mean platelet volume necessary in breast cancer patients?
  68. Resectable single hepatic epithelioid hemangioendothelioma in the left lobe of the liver: a case report
  69. Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
  70. The CCR5-Delta32 genetic polymorphism and HIV-1 infection susceptibility: a meta-analysis
  71. Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro
  72. Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions
  73. Analysis of patient satisfaction with emergency medical services
  74. Guillain-Barré syndrome and Low back pain: two cases and literature review
  75. HELLP syndrome complicated by pulmonary edema: a case report
  76. Pharmacokinetics of vancomycin in patients with different renal function levels
  77. Recurrent chronic subdural hematoma: Report of 13 cases
  78. Is awareness enough to bring patients to colorectal screening?
  79. Serum tumor marker carbohydrate antigen 125 levels and carotid atherosclerosis in patients with coronary artery disease
  80. Plastic treatment for giant pseudocyst after incisional hernia mesh repair: a case report and comprehensive literature review
  81. High expression levels of fascin-1 protein in human gliomas and its clinical relevance
  82. Thromboembolic complications following tissue plasminogen activator therapy in patients of acute ischemic stroke - Case report and possibility for detection of cardiac thrombi
  83. The effects of gastrointestinal function on the incidence of ventilator-associated pneumonia in critically ill patients
  84. A report of chronic intestinal pseudo-obstruction related to systemic lupus erythematosus
  85. Risk model in women with ovarian cancer without mutations
  86. Direct oral anticoagulants and travel-related venous thromboembolism
  87. How bispectral index compares to spectral entropy of the EEG and A-line ARX index in the same patient
  88. Henoch-schonlein purpura nephritis with renal interstitial lesions
  89. Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
  90. CD5 and CD43 expression are associate with poor prognosis in DLBCL patients
  91. Combination of novoseven and feiba in hemophiliac patients with inhibitors
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2018-0008/html
Scroll to top button